William Yuen
Director, Ascent Partners
Our professional team will ensure that your evolving needs for valuation will always be satisfied. For example, we could help you to assess the expected credit loss (ECL) of your trade receivables and the incremental borrowing rate (IBR) as required by the HKFRS 9 and the HKFRS 16 respectively.
In today’s ever-changing and increasingly competitive business climate; a precise, independent, and transparent assessment of value can be the deciding factor in achieving your goals.
We draw from our extensive industrial, commercial, and technical experience to deliver impartial valuations that meet international and local regulatory standards. We will work with you to cater to your needs to the best of our abilities while maintaining the highest ethical standard as an independent valuation company.
We leave no stone unturned. Our reports and certificates will thoroughly explain the methodologies, the assumptions, the considerations, the title investigation, and any limiting conditions to ensure that everything is transparent.
The most important aspect of Ascent Partners is our ability to manage the coordination of the various professional parties across multiple jurisdictions on your behalf to ensure the desired results.
We assist you in the process of determining the economic value of your business. These valuations encompass a wide range of fields and methodologies. We have the experience to determine the fair value of a business for all your needs, from financial reporting, division of ownership, and M&As.
Mr. Elmen Wong
Executive Director, Kam Hing International Holdings
Financial Instruments are a key aspect when it comes to running a business, especially when they are needed for funding or as an incentive for the important stakeholders in your business.
Let Ascent Partners be your guide when it comes to their value. We provide independent valuation for financial instruments that are in line with the established accounting and regulatory standards.
Mr. David Cheung
Company Secretary & Financial Controller, Geely Automobile Holdings Limited
Shed light on the key aspects of the value within your company by working with Ascent Partners. We understand the ins and outs of the regulatory requirements on valuation of your assets.
Mr. Andy Chan
Company Secretary & Financial Controller, Kwoon Chung Bus Holdings Limited
Property : Atlantic House
Type: Office
Client: Winfull Group Holdings Limited
Purpose: Circular disclosure
Property : Town Health Technology Centre
Type: Office
Client: Town Health International Medical Group Limited
Purpose: Financial reporting
Property : 119-122 Bayswater Road
Type: Hotel
Client: Winfull Group Holdings Limited
Purpose: Circular disclosure
Property : Bonjour Tower
Type: Industrial
Client: Bonjour Holdings Limited
Purpose: Circular disclosure
Property : 25-31 Keysborough Avenue
Type: Industrial
Client: Ausnutria Dairy Corporation Limited
Purpose: Financial reporting
Property : Daminggong Construction Materials & Furniture City – East Third Ring Store
Type: Retail
Client: Chinlink International Holdings Limited
Purpose: Financial reporting
Determining the value of natural resources and biological assets can be challenging due to the complexity and diversification of the transformation units. Ascent Partners understands the substantial impact of such valuation to the company’s financial statement and investment decisions, and we excel at it.
Mr. Jack Ding
CFO, China Agroforestry Low-Carbon Holdings Limited
Our industry expertise in IPO projects ranges from Apparel, Construction and Decoration to Packaged Food:
Year 2018
i.century Holding Limited 8507 hk
Industry:
Apparel
Year 2017
Wing Chi Holdings Limited 6080 hk
Industry:
Construction and Decoration
Year 2016
Luen Wong Group Holdings Limited 8217 hk
Industry:
Construction and Decoration
Year 2015
China Candy Holdings Limited 8182 hk
Industry:
Package Food
Year 2018
South China Financial Holdings Limited 619 hk
Project:
Discloseable Transaction
Details:
Major and connected transaction related to the acquisition of the entire issued share capital of the target companies
Year 2017
Bolina Holdings Company Limited 1190 hk
Project:
Discloseable Transaction
Details:
Acquisition of 51% of the issued share capital of the target company involving issue of new shares under general mandate
Year 2016
Lansen Pharmaceutical Holdings Limited 503 hk
Project:
Connected and Discloseable Transaction
Details:
Related to the second tranche subscription in Haotian Holdings Limited and related to the Cross Guarantee Agreement
Year 2015
Baofeng Modern International Holdings Company Limited 1121 hk
Project:
Very Substantial Acquisition
Details:
The acquisition of the technology involving the issue of convertible bonds under specific mandate
Year 2018
Yat Sing Holdings Limited 3708 hk
Project:
Major Transaction
Details:
The acquisition of 55% equity interest in the target company
Year 2017
Winfull Group Holdings Limited 183 hk
Project:
Major Transaction
Details:
Disposal of 51% equity interest in Plan Link Limited
Year 2016
New Ray Medicine International Holding Limited 6108 hk
Project:
Discloseable and Connected Transactions
Details:
Acquisitions of properties
Year 2015
Alltronics Holdings Limited 833 hk
Project:
Major Transaction
Details:
Acquisitions of properties